BusinessSportsArt Partners with The Imaginarium at I-Square’s ECO gymBy Nasdaq OMXFeb 22, 2018, 2:27 PM UTC
BusinessBioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP SystemBy Nasdaq OMXOct 26, 2017, 12:01 PM UTC
BusinessBioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards CommercializationBy Nasdaq OMXOct 24, 2017, 12:00 PM UTC
BusinessBioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022By Nasdaq OMXOct 19, 2017, 12:00 PM UTC
BusinessBioSig Technologies to Present at the Dawson James Small Cap Growth ConferenceBy Nasdaq OMXOct 13, 2017, 12:00 PM UTC
BusinessBioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization OfficerBy Nasdaq OMXOct 11, 2017, 12:00 PM UTC
BusinessNovel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017By Nasdaq OMXJun 26, 2017, 12:00 PM UTC